In January 2009 25 European Union (EU) Member States (MSs), Norway and Iceland, participated in a survey seeking information on national hepatitis B vaccination programmes. Details of vaccination policy, schedule, population groups targeted for vaccination, programme funding, vaccine coverage and methods of monitoring of vaccine coverage were obtained. Twenty (74%) countries reported that they have a universal hepatitis B vaccination programme, in addition to immunisation of at risk groups; seven (26%) countries recommend HBV for high risk groups only (with some inter-country variation on groups considered at high risk). Among countries without universal hepatitis B vaccination programmes, the major factor for non-introduction is low disease endemicity.(R.A.)
Auteur : Mereckiene J, Cotter S, Lopalco P, D'Ancona F, Levy Bruhl D, Giambi C, Johansen K, Dematte L, Salmaso S, Stefanoff P, O'Flanagan D
Vaccine, 2010, vol. 28, p. 4470-7
